Company / Revenue
Beam Therapeutics Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$139.7M
FY2025
5-year range
$51.8M / $377.7M
FY2021-FY2025
Trend
+120.0%
vs FY2024
Sector context
#101 of 155
Health Care
What the data says
At $140M, Beam Therapeutics Inc.'s revenue ranks #101 of 155 in the Health Care sector. Declined from $378M to $140M over the past 2 years.
Based on SEC 10-K filings.
$140M in FY2025 with a 5-year CAGR of +499.8%.
Declined from $378M to $140M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +31.9%
- 5-Year CAGR
- +499.8%
- 10-Year CAGR
- -
Sector benchmark
#101 of 155 in Health CareTop 65% of 155This company $139.7M Sector average $4.5B
▼
-96.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +499.8%, indicating consistent growth.
- In FY2025, revenue increased 120.0% year-over-year.
- Ranks #101 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $139.7M | +120.0% |
| FY2024 | $63.5M | -83.2% |
| FY2023 | $377.7M | +520.0% |
| FY2022 | $60.9M | +17.5% |
| FY2021 | $51.8M | +287922.2% |
| FY2020 | $18.0K | +0.0% |
| FY2019 | $18.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026